Introduction
The nuclear factor-kB (NF-kB) pathway is a regulator of multiple aspects of immune cell functions, including lymphoid organogenesis, inflammation and lymphocytes stimulation. In the hematopoietic system, various biological outcomes are mediated by NF-kB ranging from inflammation to cellular proliferation and to date more than 200 NF-kB-responsive genes have been identified. Most of the stimuli leading to the activation of the NF-kB pathway are integrated by the activation of the IkB kinase (IKK) complex composed of two catalytic subunits IKKa/IKK1 and IKKb/IKK2 and the regulatory subunit NF-kB essential modulator (NEMO)/IKKg (Pahl, 1999) . NF-kB inhibitors (IkB) maintain NF-kB/Rel dimers in an inactive state within the cytoplasm. Their specific phosphorylations by IKK induce their ubiquitylation and proteasomal degradation and allow the release and translocation of NF-kB factors to the nucleus (Ghosh and Karin, 2002) . Beside the classical NF-kB pathway, an alternative pathway is activated in response to some B-cell maturation and lymphoid organogenesis signals (lymphotoxins a/b, CD40L and Blys/BAFF). It only depends on IKKa and its upstream NF-kB inducible kinase (NIK) and involves the processing of the NF-kB2/p100 product into mature p52 and subsequent nuclear translocation of p52/RelB heterodimers (Ghosh and Karin, 2002) .
One line of evidence linking the NF-kB pathway to neoplastic transformation first comes from the broad range of gene responsive to NF-kB factors and associated with cell growth, migration, survival or angiogenesis (Baldwin, 2001; Richmond, 2002) . Moreover, NF-kB participates in oncogenesis through functional links with major effectors of tumorigenesis as b-catenin (Deng et al., 2002) and the tumor suppressors ARF (Rocha et al., 2003) and p53 (Tergaonkar et al., 2002) . Recently, the induction of proinflammatory cytokines by NF-kB factors was shown to influence cancer progression in mouse models (Greten et al., 2004; Pikarsky et al., 2004) . Interestingly, the IKKb/NF-kB-dependent paracrine production of proinflammatory cytokines by myeloid cells present in tumor microenvironments was shown to favor tumor growth whereas it does not affect the apoptotic sensitivity of malignant cells or the early stages of tumor development (Greten et al., 2004) , illustrating the multiple ways in which NF-kB contributes to the oncogenic process. Activation of NF-kB also interferes with the inherent or drugs-induced susceptibility of tumor cells to apoptosis. For example, inhibitors of apoptosis (IAP) proteins are encoded by NF-kB-target genes and exert their antiapoptotic functions through a direct inhibition of caspases (Liston et al., 2003) . IAPs are barely detectable in normal differentiated cells but individual members are aberrantly expressed in transformed cells, as X-linked IAP (XIAP), which is constitutively and highly expressed in Reed-Sternberg cells of Hodgkin's lymphomas and appears as the main mediator of apoptotic resistance of these lymphomas (Kashkar et al., 2003) . IAP are supposed to confer resistance to apoptosis induction by antitumor drugs whereas normal cells harbor low dependency on IAPs.
NF-kB has been found constitutively activated in series of human cell lines and samples derived of solid or hematopoietic tumors such as chronic myeloid leukemia (CML) (Kirchner et al., 2003) , acute leukemias (Kordes et al., 2000; Guzman et al., 2001; Baumgartner et al., 2002) , multiple myelomas (Feinman et al., 1999) and lymphomas of various types (Davis et al., 2001; Savage et al., 2003) . In hematopoietic tumors, NF-kB activation may occur through amplifications, mutations and/or chromosomal rearrangements of genes encoding NF-kB subunits themselves or relays of the pathway as the Bcl10 and Malt1 proteins, which link the antigen receptors to the IKK complex in normal lymphoid cells (Rayet and Gelinas, 1999; Weil and Israel, 2004) . Leukemogenic viral proteins also activate NF-kB partly through interactions with IKK and IKK-interacting factors (Sun and Ballard, 1999; Matta and Chaudhary, 2004) . The leukemia-associated Bcr-Abl and TEL-tyrosine kinase fusion proteins partly proceed through NF-kB activation for their transformation of hematopoietic cells (Besancon et al., 1998; Constantino Rosa Santos et al., 2001; Kirchner et al., 2003) . Although NF-kB activity is dispensable for Bcr-Abl-mediated inhibition of apoptosis upon cytokine withdrawal in cell lines, it is essential for its tumorigenicity in nude mice (Reuther et al., 1998) . Several aspects of the pathways downstream of these oncoproteins and implicated in NF-kB activation remain however elusive. In a previous study we illustrated the role exerts by NF-kB in the antiapoptotic properties of the TEL-Jak2 and TEL-Abl oncogenes (Constantino Rosa Santos et al., 2001) . The aim of this study was to define the signal relay responsible for their sustained NFkB activity and to characterize the relevant NF-kB-target genes that contribute to their antiapoptotic activity. Furthermore, we examined the induction of NF-kB by oncogenic forms of the Fms-like tyrosine kinase 3 (Flt-3), which have frequently been associated with human acute myelogenous leukemias (AML) and whose expression correlates with decreased response to chemotherapy and poor prognosis (Gilliland and Griffin, 2002) .
Results
Ba/F3 cells transformed by TEL-Jak2 and TEL-Abl accumulate anti-apoptotic IAP1, IAP2 and XIAP proteins Our previous data showed the role of the NF-kB pathway in the anti-apoptotic activities of TEL-Jak2 and TEL-Abl in the murine lymphoid pro-B Ba/F3 cells (Constantino Rosa Santos et al., 2001) . To impact the role of pro-survival proteins known to be NF-kB targets, we examined the expression of FLICE-inhibitory protein (FLIP) (Micheau et al., 2001 ) whose elevated expression has been shown to promote tumor establishment (Djerbi et al., 1999; Medema et al., 1999) and of members of the IAP family frequently overexpressed in tumors, i.e. IAP1, IAP2 and XIAP. A quantitative PCR analysis did not reveal enhanced transcriptional induction of these genes in oncogeneexpressing cells when compared to parental cells (data not shown). In contrast, Western blot analysis revealed a strong accumulation of IAP1, IAP2 and to a lesser extent of XIAP in oncogene-expressing cells when compared to parental cells, whereas FLIP protein levels stayed almost identical between the cell lines ( Figure 1a) . To impact the functional role of IAP1/2 and XIAP accumulations, TEL-Jak2 and TEL-Abl-expressing cells were analysed for their resistance to etoposide-triggered apoptosis (Figure 1b) , a process known to be partly IAP-dependent (Liston et al., 2003) . While the kinetics of apoptosis induction of parental cells was rapidly achieved with a maximum killing at 36 h, rates of apoptotic cells obtained at the same period were roughly 2-folds lower for the two transformed cell lines. These findings indicate that although apoptotic cell death cannot be overcome, normal and transformed cells demonstrate differential sensitivity to a IAP-dependent apoptotic inducer.
When TEL-Jak2-expressing and parental Ba/F3 cells were subjected to etoposide exposure, a major decreased in IAP1 levels was observed for parental cells matching with their engagement into apoptosis, while this decrease was faint in the TEL-Jak2 context ( Figure 1c ). In contrast, accumulation of IAP2 remained stable during etoposide stimulation in both cell lines. IAP1 expression was restored when cells were treated with the proteasome inhibitor MG115, indicating that a proteasome-dependent degradation is involved in the regulation of IAP1 in these cells, which may be subverted by TEL-Jak2. Further experiments will be required to assess whether TEL-Jak2 may also induce the up-regulation of IAP1 through an increase in rate of protein synthesis.
Ba/F3 cells transformed by the fusion proteins do not show major modifications of the subcellular distribution of effectors of the NF-kB pathway We previously reported the sustained activation of NFkB/Rel complexes in TEL-Jak2-and TEL-Abl-expressing Ba/F3 cells (Constantino Rosa Santos et al., 2001) . To extend this analysis, we examined by Western blot the subcellular distribution of NF-kB signaling effectors (Figure 2a and b) . The two cell lines showed a constitutive nuclear localization of p52 and RelB known to form transcriptionally active NF-kB dimers while only modest amounts of c-rel were nuclear. This latter observation was unexpected since c-rel nuclear translocation has been recurrently associated to oncogenic processes either in cultured hematopoietic cells or in human lymphoid proliferations (Gilmore et al., 2004) . p65/RelA which are transactivation partners of p50, p52 and RelB were found both in the cytoplasmic and nuclear fractions. As a similar subcellular distribution was observed in parental Ba/F3 cells cultured in the presence of WCM, these patterns attest the dynamics of IL-3-induced NF-kB activation and illustrate the capability of the leukemogenic fusion proteins to mimic this process. Phosphorylated serine536-p65/RelA species were also detected in the three cell lines; such phosphorylation of the p65 subunit has been reported in hematopoietic cells upon cytokine or LTb induction (Hayden and Ghosh, 2004) and as the consequence of the viral protein Tax-mediated cellular transformation (O'Mahony et al., 2004) . The IkB-related B-cell leukemia/lymphoma 3 (Bcl-3) was found in nuclear extracts as repeatedly reported in lymphoid cells, where it is known to participate to the induction of NF-kBtarget genes in association with p50 and p52 (Dechend et al., 1999) . Finally, enhanced protein levels of IkBa (but not IkBb and IkBe) and of phospho-ser32/36-IkBa were detected in nuclear and cytoplasmic fractions of the two oncogene-expressing cells when compared to parental cells (Figure 2a ). mRNA levels of IkBa known to be bona fide NF-kB target, was measured by quantitative PCR and estimated as two-fold higher in the two oncogene-expressing cell lines when compared to proliferating parental cells, in keeping with an active NF-kB pathway in these two cellular contexts ( Figure 2c ). In keeping with the accumulations of NFkB1 and NF-kB2 proteins in TEL-Jak2-expressing cells, transcript levels were estimated as two-fold higher in this cell line when compared to proliferating parental and TEL-Abl-expressing cells (Figure 2c ). Reasons of this transcriptional induction are unknown. The accumulation of phospho-IkBa and NF-kB1/p105 detected in TEL-Jak2-expressing cells prompted us to analyse the b-transducin repeat-containing protein1 (b-TrCP1) known to regulate the processing/degradation of NF-kB precursors p105 and p100 and IkBa (Fuchs et al., 2004) . However no significant difference was seen between parental and transformed cells in b-TrCP1 protein levels ( Figure 2a ). Tyrosine phosphorylations have been reported to lead to the persistent cytoplasmic expression of IkBa in lymphoid cell lines (Imbert et al., 1996; Beraud et al., 1999) or to directly result from Jak2 activity in a neuronal cells model (Digicaylioglu and Lipton, 2001 ), but in vitro experiments invalidate a direct phosphorylation of IkBa by the TEL-Jak2 fusion kinase (data not shown). In keeping, IkBa behaves as normally regulated in TEL-Jak2-expressing cells since it is sensitive to proteasomal degradation and is functionally affected by the expression of the super-repressor form IkBa SS/AA (not shown).
TEL-Jak2-and TEL-Abl-transformed Ba/F3 cells showed a specific and constitutive activity of IKKa To assess a role of the IKK complex in the oncogenemediated NF-kB activation, IKKa and IKKb kinases were co-immunoprecipitated from cytoplasmic extracts of the different cell lines by using an anti-IKKg/NEMO antibody and immune complexes were subjected to an Figure 3a , middle part, lanes 8 and 12), while phosphorylation was low or undetectable when incubated with the mutant GST-IkBa SS/AA form (lanes 9 and 13) or GST protein alone (lanes 7 and 11). Protein species present in immune complexes were separated on SDS-PAGE gel and direct autoradiography of the membrane identified IKKa as the prominent phosphorylated kinase in the lysates from TEL-Jak2-and TEL-Abl-expressing cells (Figure 3a , upper part, lanes 6-13). In contrast, we observed a specific IKKb phosphorylation in kinase assays performed with extracts from parental cells maintained in WCM. IKKb functional activation was further confirmed by the incorporation of radioactivity in wt GST-IkBa substrates (lanes 3-5). Of note, only small amounts of phosphorylated IKKb species were detected in transformed cell lines. In addition, rates of radioactivity incorporated into the immunoprecipitated IKKa proteins or in GST-IkBa and GST-IkBa SS/AA synthetic substrates were found higher in lysates from TEL-Jak2-expressing cells than in cells transformed by TEL-Abl (Figure 3b ). Even though the underlying mechanisms are unknown, increased IKKa activity may partly be explained by the sustained IKKa protein expression observed in the TEL-Jak2 cellular context, while IKKg/ NEMO and IKKb protein levels remained constant between transformed or parental cells (Figure 2a ). Consistent with a role for IKKa in the oncogenemediated induction of NF-kB pathway, transfections of increasing amounts of a kinase-inactive (IKKa K44A ) (Ling et al., 1998) or a mutant form (IKKa SS/AA ) of IKKa in TEL-Jak2-expressing Ba/F3 cells demonstrated a marked decrease in the NF-kB-dependent activity of a luciferase reporter gene while cells transfected with a wt form (IKKa wt ) did not significantly differ from those transfected with the empty vector pCDNA3 alone (Figure 3d ). Similar defects were observed in TEL-Ablexpressing Ba/F3 cells (data not shown).
IKKa is required for a functional TEL-Jak2-induced NF-kB activity To confirm the role of the IKK complex in TEL-Jak2-mediated NF-kB nuclear accumulation, we transiently transfected MEF cells deficient for IKKa, IKKb or IKKa-dependent activation of NF-jB by oncoproteins S Malinge et al IKKg/NEMO with expression vectors for the two oncogenes and NF-kB nuclear accumulation was further analysed by EMSA (Figure 4a ). It is assumed that the classical NF-kB activity remains largely intact in IKKa À/À cells. Nuclear extracts from wt MEFs stimulated for 30 min with TNFa or IL1b were used to detect functional DNA binding NF-kB complexes (lanes 2 and 3). These complexes consist of abundant p65/p50 and p50/p50 dimers as identified by super-shift analyses (not shown). In wt MEFs, expression of TEL-Jak2 and TEL-Abl induced a dose-dependent functional activation of NF-kB complexes while a minimal NFkB induction independent of oncogene expression levels was observed in IKKg/NEMO-deficient cells treated as above. NF-kB functional activity was moderately impaired in IKKb À/À cells while the loss of IKKa totally abolished the ability of the oncogenes to induce a dosedependent NF-kB DNA binding activity.
Reconstitution of IKKa À/À cells with increasing amounts of wt IKKa restored the full TEL-Jak2-mediated induction of functional NF-kB DNA binding activity in a range comparable to the one observed upon IL1b stimulation (Figure 4b , compare lanes 7-9 and 2-4, respectively). TEL-Jak2-mediated IKKa functional activation was further supported by a concomitant cytoplasmic accumulation of phosphorylated-Ser536 p65 factors, as observed in wt MEFs upon IL-1b induction. Expression of wt IKKa and TEL-Jak2 in IKKa À/À cells was confirmed by Western blotting of the lysates with an anti-IKKa and an anti-phosphotyrosine antibody respectively (Figure 4b, lower panel) .
Mutant Flt-3 proteins induce NF-kB activation through IKKa
Mutations within the Flt-3 receptor tyrosine kinase are the most common molecular defect identified in AML. We examine the ability of two mutated Flt-3 proteins to induce NF-kB activation by transient transfections of MEFs. The internal tandem duplication (ITD) and D835Y substituted Flt-3 mutants possess a constitutive kinase activity consecutive to mutations of amino acids within their juxtamembrane domain and kinase activation loop respectively, and transform hematopoietic cells in cellular and mouse models (Kelly et al., 2002) . As shown Figure 4c , their expression in wt MEFs induced a functional activation of NF-kB (lanes 6-13) with a prominent p65/p50 dimers nuclear translocation, while it was more modest for the wt Flt-3 used as control (lanes 2-5). Note that transfection of the empty IKKa-dependent activation of NF-jB by oncoproteins S Malinge et al MSCV/Neo vector alone resulted in low NF-kB activity (lane 1). NF-kB luciferase reporter assays performed on Ba/F3 cells transfected with the above expression vectors confirmed their ability to functionally activate this pathway (data not shown). Remarkably, only the loss of IKKa impaired Flt-3-mediated NF-kB activation (Figure 4d , lanes 6-8) whereas IKKbdeficient cells allowed the nuclear translocation of dimers (Figure 4d, lanes 10-12) . These experiments indicate that these two recurrent leukemogenic forms of Flt-3 are potent activators of NF-kB. Taken together, our findings highlight the requirement of IKKa in NF-kB induction for these oncogenic tyrosine kinases.
Discussion
Tyrosine kinases are frequently activated in acute and chronic leukemias by activating mutations leading to unregulated activations of mitogenic and/or antiapoptotic signaling. Among them, increased and/or constitutive activity of the NF-kB pathway is seen in most hematopoietic tumors and presumed to promote tumor progression. Here, we show that induction of NF-kB activity by different leukemogenic tyrosine kinases (TEL-Jak2, TEL-Abl and two mutant forms of Flt-3) specifically results from activation of IKKa.
Several mechanisms have been evoked for Bcr-Ablmediated NF-kB activation in hematopoietic cells including Ras-dependent and IKK-independent stimulation of nuclear translocation and transactivation function of p65/RelA (Reuther et al., 1998; Hanson et al., 2003; Kirchner et al., 2003) and implication of the MEK kinase 1 (MEKK1) (Nawata et al., 2003) . Involvement of members of the src kinase family required for in vivo Bcr-Abl leukemogenic properties (Hu et al., 2004) , and known to stimulate NIK activity and to phosphorylate IKK directly (Huang et al., 2003) has also been reported. The present and previous studies (Constantino Rosa Santos et al., 2001) agree that the TEL-Abl oncogene, as well as Bcr-Abl, activates NF-kB but in a manner that presumably involves IKKa and do not strongly affect the p65/RelA nuclear translocation process (Figure 2a ). Although these two oncogenic forms of Abl can activate Ras when expressed in hematopoietic cells (Million et al., 2004) , they also harbor substrate's specificities in experimental models (Voss et al., 2000) and distinct in vivo leukemogenic properties (Million et al., 2002) that support the hypothesis of unrelated mechanisms in NF-kB induction by these two kinases.
Of all stimuli, the most common feature leading to the activation of NF-kB in hematopoietic cells is the activation of one of the IKK kinases. Beside mechanisms of trans-phosphorylation by the IKK themselves, multiple kinases have been suggested to act as IKK kinases (Hayden and Ghosh, 2004) and activation by tyrosine phosphorylations has also been reported (Ten et al., 1999; Petro et al., 2000) . Although activation of IKKa is well defined in the alternative pathway where its depends on NIK (Senftleben et al., 2001) , its activation remains ill-characterized in the canonical signaling. In T cells for example, NF-kB induction can be triggered through a TCR-independent recruitment and activation of Vav-1/IKKa complexes (Piccolella et al., 2003) . In leukemogenesis, a specific role of IKKa has emerged in regard of its implication in the transforming activities of viral proteins Luftig et al., 2004; Matta and Chaudhary, 2004; O'Mahony et al., 2004) and in transgenic model of T-cell lymphomagenesis (Bellavia et al., 2000) . Regarding TEL-Jak2, we failed to obtain functional data on NIK activity in our model and could neither demonstrate phospho-tyrosine IKKa species nor physical interactions between TEL-Jak2 and the IKK complex, suggesting that activation of IKKa do not involve its direct phosphorylation by the oncogene (data not shown). New tools will be needed to investigate the status of NIK, which regulate the processing of NF-kB2 by IKKa (Xiao et al., 2004 ) a process seemingly not altered in our cell lines. Indeed, the evaluation of accumulated p100 and p52 in the two oncogene-expressing cell lines did not reveal modified precursor-to-product ratios nor altered nuclear p52 production when compared to the parental cells cultured in the presence of WCM where IKKb is active (Figure 2a) , suggesting thus that the sustained IKKa activity detected in the transformed cells may be uncoupled from IKKa-mediated p100 processing. In keeping with a constitutive NF-kB1/p105 processing, the ratio of p105 precursor to p50 product remained constant in all the three cell lines. Nevertheless, alternative NF-kB pathway is coupled to a continuous de novo p100 protein synthesis (Mordmuller et al., 2003) and additional data on protein half-life are needed to rule out any possible effect of IKKa on p100 processing. Importantly, our results illustrate the capacity of oncogenic forms of the Flt-3 receptor tyrosine kinase to functionally induce NF-kB, while activating Flt-3 mutations have been detected in about 30% of acute myelogenous leukemias and associated to a poor prognostic (Gilliland and Griffin, 2002) . This is of interest since some of the anti-apoptotic signalings activated by these oncogenic Flt-3 proteins differ from those used by the wt receptor in physiological conditions and may represent therapeutic targets (Minami et al., 2003) .
Overexpression of IAP1, IAP2 and XIAP in TELJak2-and TEL-Abl-transformed cells correlates with a delayed etoposide-induced apoptosis ( Figure 1b) and with an inefficient activation of the caspase 9, a substrate of IAP, in the TEL-Jak2 context (MJ Pebusque, personal communication) . Delayed Fasinduced apoptosis were also observed in these cells suggesting that additional defects in other apoptotic pathways exist (not shown). Consistent with previous reports (Tamm et al., 2000) we observed important differences between IAP1, IAP2 and XIAP mRNA and protein levels. IAP/XIAP accumulation appears to rely on differential protein turn-over and/or enhanced translation rather than direct NF-kB-mediated induction of the genes, a notion supported by the presence of an internal ribosome entry site (IRES) within XIAP transcript (Holcik et al., 1999) . In regard, increased levels of translation initiation factors and sustained activation of protein synthesis initiation have been documented in a series of malignant proliferations (Bjornsti and Houghton, 2004) and demonstrated to functionally impact the leukemogenic capacity of BcrAbl (Perrotti and Calabretta, 2004) . The constitutive activation of regulators of translation mammalian target of rapamycin (mTOR) and p70S6 kinase in Ba/F3 cells transformed by TEL-Jak2 (Guasch et al., 2001 ) might facilitate accumulations of IAP/XIAP proteins. In addition to blocking apoptosis, IAPs are also involved in diverse cellular process including cell cycling (survivin and XIAP) or ubiquitylation and receptor-mediated signaling (XIAP, IAP1, IAP2). For instance, ubiquitylation by IAP1 of the IKKg/NEMO regulatory subunit is one of the critical events in IKK activation upon TNFa induction (Tang et al., 2003) . Thus, IAP overexpression may also have important functional implications for cytokine responses of hematopoietic cells expressing these oncogenic tyrosine kinases.
Materials and methods

Plasmids
The pCDNA3-TEL-Jak2 and pCDNA3-TEL-Abl expression vectors have been previously described . Expression vector for the human wild-type (wt) (IKKa wt ) was kind gift of R Weil (Institut Pasteur, Paris). The human IKKa K44A and the IKKa SS/AA (substituted on serine 176 and 180 by alanine residues) mutants were generated using site directed mutagenesis (Quickchange, Stratagene), cloned into the pCDNA3 vector and confirmed by full-length DNA sequencing. Murine stem cell virus (MSCV)/Neo retroviral vectors encoding the internal tandem duplication (ITD), the D835Y-substituted mutant and the wt Flt-3 were given by L Kelly and DG Gilliland (Kelly et al., 2002) .
Cell lines and transfections conditions
Parental Ba/F3 cells were grown in RPMI 1640 medium (Gibco-BRL) with 10% fetal calf serum, 2 mM L-glutamine, and 5% WEHI-conditioned medium (WCM) as a source of IL-3. The IL-3-independent Ba/F3 cell line stably expressing the TEL-Jak2 and TEL-Abl fusion proteins have been reported (Constantino Rosa Santos et al., 2001) . The murine embryonic fibroblasts (MEF) IKKg/NEMO À/À and wt cell lines were obtained from A Israel's laboratory (Institut Pasteur, Paris) and the IKKa À/À and IKKb À/À MEF (Li et al., 1999) cells were obtained from V Baud (CNRS, UPR 9079, Villejuif, France). MEFs were maintained in Dubelcco's Modified Eagle's Medium (Gibco-BRL) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin and 100 mg/ml streptomycin. Cells, 0.4 Â 10 6 , were transfected with the indicated expression vectors using the Lipofectin reagent (Gibco-BRL) in OPTI-MEM medium for 5 h. MEFs were stimulated for 30 min or 1 h with 10 ng/ml of murine recombinant TNFa or IL-1b (R&D systems) before lysis. Fractionated cell extracts were prepared 48 h post-transfection. NF-kB-luciferase reporter assays were performed in Ba/F3 cells as previously reported (Constantino Rosa Santos et al., 2001) .
In cell survival experiments, cells were incubated in the presence of 50 mM of etoposide (VP16-Calbiochem) or dimethylsulfoxide (DMSO) used as a solvent and numbers of living cells were estimated at the indicated times by blue trypan exclusion. The proteasome inhibitor MG115 was from Calbiochem and used at 100 mM.
In vitro kinase assay Cytoplasmic extracts were prepared in 0.2% NP40, 20 mM HEPES pH8, 10 mM KCl, 10% glycerol, 1 mM EDTA, in the presence of inhibitors of phosphatases (50 mM orthovanadate, 2 mM sodium fluoride) and of proteases (Completet, Roche Diagnostics). 0.8-1 mg of clear cell lysates were incubated at 41C with 2 ml of a rabbit polyclonal anti-IKKg antibody for 4 h. Immune complexes were collected with Protein A Sepharoset 6 Mb beads, washed two times in the above buffer and once in kinase assay reaction buffer (10 mM HEPES pH7.4, 1 mM MnCl 2 , 5mM MgCl 2 , 12.5 mM b-glycero-2-phosphate, 50 mM dithiothreitol, 50 mM orthovanadate, 2 mM sodium fluoride). Immune complexes were then incubated at 301C for 30 min in the above buffer with 10 mCi of (g-32 P)ATP and 2 mg of glutathion-S-transferase (GST) proteins GST, GST-IkBa 1À72 or GST-IkBa 1À72 SS/AA (S32A/S36A) (provided by G Courtois, Institut Pasteur, Paris). Reactions were stopped by the addition of an equal volume of 10 mM TRIS, 1 mM EDTA, 100 mM NaCl, 0.5% Triton, 0.5% Tween-20. Products were boiled for 5 min, protein species were separated on a 10% SDS-PAGE and blotted on a nitrocellulose membrane (BA85, Schleicher and Schuell). Phosphorylated protein species were revealed by direct autoradiography of the membranes and further identified by Western blot.
Immunoblot analysis
Protein extractions (nuclear (NE) and cytoplasmic (CE)) were performed as reported (Pallard et al., 1995) . Soluble cell extracts were performed in 1% NP40, 150 mM NaCl, 50 mM TRIS/HCl pH7.8 and 2 mM EDTA in the presence of phosphatases and proteases inhibitors. For Western blotting, 100-200 mg of lysates were separated by electrophoresis on 8% SDS-PAGE, transferred to nitrocellulose membranes and incubated with the indicated antibodies. Antibodies against the murine NF-kB1/p105, NF-kB2/p100, p65/RelA, RelB, c-rel, Bcl-3 and b-TrCP1 were purchased from Santa Cruz; anti-IAP1, IAP2, XIAP and FLIP antibodies were from R&D System. Anti-IkBa, anti-phosho-IkBa (Ser32/36) and antiphospho-Ser536-p65 were from Cell Signaling and anti-IKKa and IKKb were obtained from Upstate Biotechnology. Anti-IKKg/NEMO, IkBb and IkBe antibodies were obtained from A Israel's laboratory (Institut Pasteur, Paris). Immune complexes were detected using the ECL þ detection kit (Amersham).
EMSA Nuclear extracts and electrophoretic mobility shift assays (EMSA) were performed as reported (Pallard et al., 1995; Constantino Rosa Santos et al., 2001 ) using the 32 P-labeled NF-kB probe (AGTTGAGGGGACTTTCCCAGG).
Quantitative PCR analysis
Quantitative PCR analysis was performed on an ABI PRISM 7000 Sequence Detection System using the SyberGreen I Dye (Applied Biosystem). Total RNA from the different cell lines were prepared using the RNA Blue reagent (Gibco-BRL) and 5 mg were reverse transcribed in 25 ml using the Superscript II Reverse transcriptase (InVitrogen) following the manufacturer's instructions. 1/20-1/200 of cDNA products were amplified in triplicate by quantitative PCR using the SyberGreen Master Mix reagent (Applied Biosystem) and 7.5 pmoles of each primer. Primers were designed using the Primer Express software (Applied Biosystem). Runs were performed at annealing temperatures ranging from 60 to 621C, depending on the set of primers. Primer sequences were as follows: NF-kB1 F: 5 0 -TTGCCTATCTACAAGCAGAAGG-3 0 , NF-kB1 R: 5 0 -ACGCTCAGGTCCATCTCCTTGG-3 0 ; IkBa F: 5 0 -GCACCTAGCCTCTATCCACG-3 0 , IkBa R: 5 0 -CTCCTGAGCGTTGACATCAGCA-3 0 ; ABL F: 5 0 -CGAAG CAGCTCGATGGAAC-3 0 , ABL-R: 5 0 -CCAAGACCCGGA GCTTTTC-3 0 ; NF-kB2-F: 5 0 -GGATCTGAGCATTGTACG GCTG-3 0 , NF-kB2-R: 5 0 -CCTGGAGACTTGCTGTCAT GG-3 0 . The 2 ÀDDCt method described in (Livak and Schmittgen, 2001 ) was used for analyses referring to c-Abl transcripts as internal control and parental Ba/F3 cells cultured in WCM as calibrator.
